PRESICCE, FABRIZIO
 Distribuzione geografica
Continente #
NA - Nord America 1.472
EU - Europa 416
AS - Asia 144
SA - Sud America 18
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 2.053
Nazione #
US - Stati Uniti d'America 1.459
IT - Italia 192
SE - Svezia 111
IN - India 79
CN - Cina 59
IE - Irlanda 36
FI - Finlandia 23
AR - Argentina 17
NL - Olanda 14
CA - Canada 12
UA - Ucraina 9
GB - Regno Unito 8
RO - Romania 8
DE - Germania 6
FR - Francia 3
JP - Giappone 3
BE - Belgio 2
MY - Malesia 2
AU - Australia 1
CH - Svizzera 1
CO - Colombia 1
ES - Italia 1
EU - Europa 1
MX - Messico 1
PL - Polonia 1
RU - Federazione Russa 1
SC - Seychelles 1
VN - Vietnam 1
Totale 2.053
Città #
Fairfield 269
Ashburn 134
Woodbridge 111
Houston 107
Seattle 107
Cambridge 94
Wilmington 86
Chandler 84
Beijing 50
Ann Arbor 49
Princeton 48
Rome 47
Dublin 36
San Paolo di Civitate 35
Plano 30
Lawrence 26
Millbury 25
San Diego 20
Boston 18
Federal 17
Andover 13
Dearborn 12
Padova 10
Columbus 9
Norwalk 9
Florence 7
Milan 7
Toronto 7
New York 5
Fredericton 4
Marigliano 4
Naples 4
Southend 4
Taranto 4
Trevignano Romano 4
Boardman 3
Bremen 3
Des Moines 3
Falls Church 3
Fremont 3
Redmond 3
Trento 3
Agugliano 2
Bagnoli di Sopra 2
Brussels 2
Buffalo 2
Campi Bisenzio 2
Catania 2
Civita Castellana 2
Hefei 2
Helsinki 2
Jinan 2
Köln 2
London 2
Ormelle 2
Palermo 2
Pieve d'Olmi 2
Pistoia 2
Puchong Batu Dua Belas 2
Redwood City 2
Tokyo 2
Verona 2
Akita 1
Ardea 1
Avigliano 1
Bologna 1
Botricello 1
Caltanissetta 1
Cardiff 1
Ciampino 1
Cosenza 1
Downers Grove 1
Glassboro 1
Hanoi 1
Jacksonville 1
Kunming 1
Madrid 1
Mahé 1
Medellín 1
Mexico 1
Montclair 1
Pozzuoli 1
Praia A Mare 1
Pune 1
San Mateo 1
Seversk 1
Shanghai 1
Shaoxing 1
Shenyang 1
Simi Valley 1
Umeå 1
Vancouver 1
Totale 1.587
Nome #
The evolving picture of lower urinary tract symptom management 94
Risultati funzionali a lungo termine della cistectomia radicale robot-assistita (RARC) con diversione urinaria totalmente intracorporea (ICUD) 88
Serum level of chromogranin are not predictive of high grade poorly differentiated prostate cancer: results from an italian biopsy cohort 77
Metabolic Syndrome Does Not Increase the Risk of Ejaculatory Dysfunction in Patients With Lower Urinary Tract Symptoms and Benign Prostatic Enlargement. An Italian Single-center Cohort Study 74
Physical activity as a risk factor for prostate cancer diagnosis. a prospective biopsy cohort analysis 72
Combination therapies for improved management of lower urinary tract symptoms/benign prostatic hyperplasia 71
On-clamp versus off-clamp partial nephrectomy: propensity score-matched comparison of long-term functional outcomes 68
null 63
Clinical Implications for the Early Treatment of Benign Prostatic Enlargement (BPE). a Systematic Review 63
null 61
Detrusor overactivity increases bladder wall thickness in male patients: a urodynamic multicenter cohort study 61
MP35-11 METABOLIC ABNORMALITIES LINKED TO AN INCREASED CARDIOVASCULAR RISK ARE ASSOCIATED WITH HIGHER STORAGE LOWER URINARY TRACT SYMPTOMS 61
Inflammatory mediators in the development and progression of benign prostatic hyperplasia 60
Metabolic abnormalities linked to an increased cardiovascular risk are associated with high-grade prostate cancer. a single biopsy cohort analysis 60
Editorial Comment from Dr Presicce et al. to Emerging links between non-neurogenic lower urinary tract symptoms secondary to benign prostatic obstruction, metabolic syndrome and its components. a systematic review 59
Patients with prostatic inflammation undergoing transurethral prostatic resection have a larger early improvement of storage symptoms 59
OPERATIVE TIME IS ASSOCIATED WITH POST-OPERATIVE TURB COMPLICATIONS: A MODIFIED CLAVIEN CLASSIFICATION SYSTEM ANALYSIS 58
Tamsulosin or silodosin adjuvant treatment is ineffective in improving shockwave lithotripsy outcome. A short-term follow-up randomized, placebo-controlled study 57
Variations of nighttime and daytime bladder capacity in patients with nocturia. implication for diagnosis and treatment 57
Contemporary monopolar and bipolar transurethral resection of the prostate: prospective assessment of complications using the Clavien system 56
Castration resistance prostate cancer. what is in the pipeline? 56
Serum levels of 17-β-estradiol are not predictive of prostate cancer diagnosis and aggressiveness: results from an Italian biopsy cohort. 55
null 53
Transrectal-ultrasound prostatic biopsy preparation. Rectal enema vs. mechanical bowel preparation 53
Late complications of robot-assisted radical cystectomy with totally intracorporeal urinary diversion 51
null 50
Male sexual dysfunction in patients with chronic end-stage renal insufficiency and in renal transplant recipients 50
Non-invasive ultrasound measurements in male patients with LUTS and benign prostatic obstruction. Implication for diagnosis and treatment 49
Cardiovascular Risk Factor and prostate cancer: a possibile link to prostate cancer aggressiveness 38
null 37
Basic methods for the assessment of health-related quality of life in uro-oncological patients 34
THE INFLUENCE OF PHYSICAL ACTIVITY ON PROSTATE CANCER DIAGNOSIS: A BIOPSY COHORT ANALYSIS 31
CARDIOVASCULAR RISK AND PROSTATE CANCER: A POSSIBLE LINK TO PROSTATE CANCER AGGRESSIVENESS 31
null 30
null 29
SERUM LEVELS OF 17-beta-ESTRADIOL ARE NOT PREDICTIVE OF PROSTATE CANCER DIAGNOSIS AND AGGRESSIVENESS 29
Longer operative time and hospital stay are associated with post-operative cystectomy complications: a modified clavien classification analysis 27
null 26
null 26
null 21
Evaluation of post-operative TURB complications: a modified clavien classification system italian cohort analysis 20
Is microsurgical technique really necessary in inguinal or sub-inguinal surgical treatment of varicocele? 19
541 Metabolic abnormalities linked to an increased cardiovascular risk are associated with higher storage lower urinary tract symptoms 16
Patient centred care for the medical treatment of lower urinary tract symptoms in patients with benign prostatic obstruction: A key point to improve patients' care - A systematic review 14
Can Long-term LUTS/BPH Pharmacological Treatment Alter the Outcomes of Surgical Intervention? 9
Current Pharmacological Treatment for Male LUTS due to BPH: Dutasteride or Finasteride? 8
Clinical significance of intravesical prostatic protrusion in the management of benign prostatic enlargement: A systematic review and critical analysis of current evidence 7
Moderate-to-high cardiovascular risk is associated with increased lower urinary tract storage symptoms in patients with benign prostatic enlargement 7
Is early benign prostatic hyperplasia (BPH) treatment worthwhile? 6
The influence of the medical treatment of LUTS on benign prostatic hyperplasia surgery: Do we operate too late? 6
The Current Indications and the Benefits of Combining a β3-Agonist with an Anticholinergic for the Treatment of OAB 6
Reply 5
Totale 2.218
Categoria #
all - tutte 5.083
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.083


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019222 0 0 0 0 0 0 2 1 0 45 100 74
2019/2020559 61 24 7 15 50 67 88 66 80 48 44 9
2020/2021202 22 17 11 9 9 4 4 58 42 12 13 1
2021/2022437 16 16 37 24 54 19 11 40 44 34 50 92
2022/2023427 86 73 17 31 47 32 28 34 52 2 24 1
2023/2024188 28 46 27 37 30 20 0 0 0 0 0 0
Totale 2.218